Mukaidani; Chise

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mukaidani; Chise.The latest application filed is for "urokinase-type plasminogen activator transgenic mouse".

Company Profile

1.11.13

Mukaidani; Chise - Higashihiroshima JP
MUKAIDANI; Chise - Higashihiroshima-shi Hiroshima
Mukaidani; Chise - Hiroshima JP
MUKAIDANI; Chise - Hiroshima-shi JP
Mukaidani; Chise - Higashi Hiroshima JP
Mukaidani; Chise - Higashi Hiroshima-shi JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Urokinase-type plasminogen activator transgenic mouse Grant 11,051,496 - Kohara , et al. July 6, 2	2021-07-06
Urokinase-type Plasminogen Activator Transgenic Mouse App 20190335724 - KOHARA; Michinori ; et al.	2019-11-07
Mouse model of hyperuricemia Grant 10,314,295 - Kakuni , et al.	2019-06-11
Urokinase-type plasminogen activator transgenic mouse Grant 9,955,675 - Kohara , et al. May 1, 2	2018-05-01
Hyperuricemia Model App 20170055504 - KAKUNI; Masakazu ; et al.	2017-03-02
Chimeric non-human animal carrying human hepatocyte Grant 9,420,769 - Oshimura , et al. August 23, 2	2016-08-23
Urokinase-type Plasminogen Activator Transgenic Mouse App 20150128298 - Kohara; Michinori ; et al.	2015-05-07
Chimeric Non-human Animal Carrying Human Hepatocyte App 20140241991 - Oshimura; Mitsuo ; et al.	2014-08-28
Polynucleotide Derived From Novel Hepatitis C Virus Strain And Use Thereof App 20140178856 - KOHARA; Michinori ; et al.	2014-06-26
Polynucleotide derived from novel hepatitis C virus strain and use thereof Grant 8,609,403 - Kohara , et al. December 17, 2	2013-12-17
Nonalcoholic steatohepatitis model rodent and fatty liver model rodent Grant 8,278,499 - Mukaidani , et al. October 2, 2	2012-10-02
Polynucleotide Derived From Novel Hepatitis C Virus Strain And Use Thereof App 20120204279 - Kohara; Michinori ; et al.	2012-08-09
Method of treating mouse carrying human hepatocytes Grant 7,871,980 - Mukaidani , et al. January 18, 2	2011-01-18
Nonalcoholic Steatohepatitis Model Animal and Fatty Liver Model Animal App 20090313710 - Mukaidani; Chise ; et al.	2009-12-17
Method of proliferating human hepatocytes and method for obtaining human hepatocytes Grant 7,560,279 - Mukaidani , et al. July 14, 2	2009-07-14
Method Of Treating Mouse Carrying Human Hepatocytes App 20090060882 - Mukaidani; Chise ; et al.	2009-03-05
Method Of Screening Candidate Drug App 20090047655 - Mukaidani; Chise ; et al.	2009-02-19
Antibody recognizing proliferative human liver cells, proliferative human liver cells and functional human liver cells App 20070196345 - Mukaidani; Chise ; et al.	2007-08-23
Antibody recognizing proliferative human liver cells, proliferative human liver cells and functional human liver cells Grant 7,220,839 - Mukaidani , et al. May 22, 2	2007-05-22
Method of proliferating human hepatocytes and method for obtaining human hepatocytes App 20050255591 - Mukaidani, Chise ; et al.	2005-11-17
Antibody recognizing proliferative human liver cells proliferative human liver cells and functional human liver cells App 20050119463 - Mukaidani, Chise ; et al.	2005-06-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.